Pro Medicus Ltd PMCUF

Morningstar Rating
$108.86 −5.19 (4.55%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PMCUF is trading at a LOCK|LvfNs premium.
Price
$114.05
Fair Value
LOCK|.W!Q$M^
Uncertainty
LOCK|F!&Bv
1-Star Price
LOCK|b.$Tl$rw
5-Star Price
LOCK|.v<%$YFW
Economic Moat
LOCK|&w<Cp
Capital Allocation
—

Trading Information

Previous Close Price
$114.05
Day Range
$108.86–108.86
52-Week Range
$74.52–210.00
Bid/Ask
$0.01 / $1,713.06
Shares Outstanding
104.47M
Market Cap
$11.37B
Volume/Avg
300 / 206

Key Statistics

Price/Earnings (Normalized)
118.66
Price/Sales
67.33
Dividend Yield (Trailing)
0.43%
Dividend Yield (Forward)
0.43%
Dividend Payment Schedule
Mar, Sep
Total Yield
0.49%

Company Profile

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2026, Pro Medicus earned 90% of revenue in North America, 7% from Australia, and the remaining 3% in Europe.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Large Growth
Total Number of Employees
75

Competitors

Valuation

Metric
PMCUF
RMD
FPH
Price/Earnings (Normalized)
118.6619.2857.54
Price/Book Value
38.404.7912.77
Price/Sales
67.335.5611.77
Price/Cash Flow
138.1816.7340.97
Price/Earnings
PMCUF
RMD
FPH

Financial Strength

Metric
PMCUF
RMD
FPH
Quick Ratio
6.721.831.59
Current Ratio
6.853.102.31
Interest Coverage
——61.51
Quick Ratio
PMCUF
RMD
FPH

Profitability

Metric
PMCUF
RMD
FPH
Return on Assets (Normalized)
29.50%19.09%17.34%
Return on Equity (Normalized)
39.88%25.91%23.25%
Return on Invested Capital (Normalized)
37.90%22.30%21.70%
Return on Assets
PMCUF
RMD
FPH

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Veeva Systems Inc Class A
VEEV
LOCK|CqM!mXpLOCK|<?W$46B
Tempus AI Inc Class A common stock
TEM
—LOCK|yn%$14B
Pro Medicus Ltd ADR
PMDIY
—LOCK|BfTsp$12B
BrightSpring Health Services Inc
BTSG
—LOCK|nB#Vx$11B
Hinge Health Inc Ordinary Shares - Class A
HNGE
—LOCK|<kzp%$8B
M3 Inc
MTHRF
—LOCK|%!$@$8B
M3 Inc ADR
MTHRY
—LOCK|sDZ!s$8B
HealthEquity Inc
HQY
—LOCK|@gs>$7B
Doximity Inc Class A
DOCS
—LOCK|hr$5B

Sponsor Center